Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
5,355 USD | -0,65% |
|
+6,96% | +47,80% |
22/06 | MannKind Corporation annuncia i risultati positivi a 17 settimane dello studio INHALE-3 | CI |
29/05 | MannKind concorda un accordo di licenza incrociata con Pulmatrix | MT |
Attività
Numero di dipendenti: 413
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Innovative Therapeutic Products and Devices
100,0
%
| 100 | 100,0 % | 199 | 100,0 % | +99,42% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 100 | 100,0 % | 199 | 100,0 % | +99,42% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Michael Castagna
CEO | Chief Executive Officer | 47 | 14/03/16 |
Sanjay Singh
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/10/22 |
Kevin Kaiserman
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/20 |
Joseph Kocinsky
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/01/03 |
Burkhard Blank
CTO | Chief Tech/Sci/R&D Officer | 69 | 24/05/23 |
Lauren Sabella
COO | Chief Operating Officer | 63 | 27/03/23 |
Investor Relations Contact | 63 | 01/06/03 | |
Steven Binder
PRN | Corporate Officer/Principal | 61 | 17/07/17 |
Karen Jaffe
LAW | General Counsel | - | 01/01/20 |
David Thomson
LAW | General Counsel | 57 | 01/01/02 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 55 | 27/11/18 | |
Anthony Hooper
BRD | Director/Board Member | 69 | 01/01/20 |
Ronald Consiglio
BRD | Director/Board Member | 80 | 01/10/03 |
Kent Kresa
BRD | Director/Board Member | 86 | 01/06/04 |
Michael Friedman
BRD | Director/Board Member | 80 | 01/12/03 |
Jennifer Grancio
BRD | Director/Board Member | 52 | 23/03/20 |
Sabrina Kay
BRD | Director/Board Member | 61 | 01/12/20 |
James Shannon
CHM | Chairman | 68 | 21/05/15 |
Michael Castagna
CEO | Chief Executive Officer | 47 | 14/03/16 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 272 315 846 | 266 771 010 ( 97,96 %) | 0 | 97,96 % |
Coordinate società
![Indirizzo MannKind Corporation(MNKD)](https://cdn.zonebourse.com/static/address/34185045.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+47,80% | 1,47 Mrd | |
+19,69% | 124 Mrd | |
+20,36% | 114 Mrd | |
+21,11% | 25,83 Mrd | |
-23,52% | 19,42 Mrd | |
-18,17% | 16,2 Mrd | |
-20,22% | 15,31 Mrd | |
+56,38% | 14,32 Mrd | |
+7,11% | 14,31 Mrd | |
-48,79% | 14,19 Mrd |
- Borsa valori
- Azioni
- Azione MNKD
- Società MannKind Corporation